Boothbay Fund Management’s Thermo Fisher Scientific TMO Stock Holding History

Boothbay Fund Management’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-19,300	Closed	-$9.36M	–	2368
2025 Q3	$9.36M	Buy	+19,300	New	+$8.98M	0.14%	172
2025 Q2	–	Sell	-7,900	Closed	-$3.93M	–	1765
2025 Q1	$3.93M	Buy	+7,900	New	+$4.28M	0.1%	270
2024 Q4	–	Sell	-14,200	Closed	-$8.78M	–	1909
2024 Q3	$8.78M	Buy	14,200 +3,500	+33%	+$2.07M	0.2%	124
2024 Q2	$5.92M	Buy	+10,700	New	+$6.13M	0.14%	179
2023 Q3	–	Sell	-9,200	Closed	-$4.8M	–	2081
2023 Q2	$4.8M	Buy	+9,200	New	+$4.96M	0.11%	223
2022 Q4	–	Sell	-500	Closed	-$254K	–	2449
2022 Q3	$254K	Hold	500	–	–	0.01%	1646
2022 Q2	$272K	Sell	500 -300	-38%	-$165K	0.01%	1533
2022 Q1	$473K	Buy	+800	New	+$460K	0.01%	1328

Other funds holding TMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Boothbay Fund Management's TMO Position: Q1 2026 in Review

Boothbay Fund Management reduced its Thermo Fisher Scientific (TMO) stake by 46% in Q1 2026, selling an estimated $710K and leaving 1,528 shares worth $751K. The position accounts for 0.01% of the portfolio, ranked #1108.

Boothbay Fund Management first reported a position in TMO in Q4 2014 and has held it in 31 quarters since. The position peaked at $13.9M in Q4 2024. 2,588 funds tracked by Wall St. Rank hold TMO as of Q1 2026.

Boothbay Fund Management held 1,528 shares of Thermo Fisher Scientific worth $751K as of Q1 2026.
Boothbay Fund Management sold 1,308 Thermo Fisher Scientific shares in Q1 2026, an estimated $710K.
Thermo Fisher Scientific made up 0.01% of Boothbay Fund Management's portfolio in Q1 2026, its #1108 holding.
Boothbay Fund Management first reported a position in Thermo Fisher Scientific in Q4 2014 and has held it in 31 quarters since.
Boothbay Fund Management's Thermo Fisher Scientific position peaked at $13.9M in Q4 2024.
2,588 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.